miR-26a regulates extracellular vesicle secretion from prostate cancer cells via targeting SHC4, PFDN4, and CHORDC1-Reference-Cited by-同舟云学术

miR-26a regulates extracellular vesicle secretion from prostate cancer cells via targeting SHC4, PFDN4, and CHORDC1

Published:2020-05 Issue:18 Volume:6 Page:
ISSN:2375-2548
Container-title:Science Advances
language:en
Short-container-title:Sci. Adv.

Author:

Urabe Fumihiko¹²³^ORCID,Kosaka Nobuyoshi¹^ORCID,Sawa Yurika¹,Yamamoto Yusuke³,Ito Kagenori²³^ORCID,Yamamoto Tomofumi¹,Kimura Takahiro²^ORCID,Egawa Shin²,Ochiya Takahiro¹³

Affiliation:

1. Department of Molecular and Cellular Medicine, Institute of Medical Science, Tokyo Medical University, Tokyo, Japan.

2. Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.

3. Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan.

Abstract

MicroRNA-based screening identifies the novel regulators of EV secretion from cancer cells.

Funder

Japan Agency for Medical Research and Development

Foundation for Promotion of Cancer Research

Kobayashi Foundation for Cancer Research

Princess Takamatsu Cancer Research Fund

NOVARTIS Foundation (Japan) for the Promotion of Science

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference36 articles.

1. Exosome: from internal vesicle of the multivesicular body to intercellular signaling device

2. Exosomes are released by cultured cortical neurones

3. Versatile roles of extracellular vesicles in cancer

4. Exosomes confer pro-survival signals to alter the phenotype of prostate cells in their surrounding environment

5. Prostate Tumor-Derived Exosomes Down-Regulate NKG2D Expression on Natural Killer Cells and CD8+ T Cells: Mechanism of Immune Evasion

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular vesicles as modifiers of epigenomic profiles;Trends in Genetics;2024-09

2. Aberrant regulation of serine metabolism drives extracellular vesicle release and cancer progression;Cell Reports;2024-08

3. High-throughput screening identifies ibuprofen as an sEV PD-L1 inhibitor for synergistic cancer immunotherapy;Molecular Therapy;2024-08

4. miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia;Scientific Reports;2024-07-02

5. Prostate cancer-derived extracellular vesicles metabolic biomarkers: Emerging roles for diagnosis and prognosis;Journal of Controlled Release;2024-07